Indium (111In) altumomab pentetate

Indium (111In) altumomab pentetate (INN) (USP, indium In 111 altumomab pentetate; trade name Hybri-ceaker) is a mouse monoclonal antibody linked to pentetate which acts as a chelating agent for the radioisotope indium-111. The drug is used for the diagnosis of colorectal cancer[1][2] but has not been approved for use.[3]

Indium (111In) altumomab pentetate
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetCEA
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

References

  1. "lnternational Nonproprietary Names for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (3). 1993. Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-22.
  2. "Cumulartive [sic] Designated Products List". U.S. Food and Drug Administration. Archived from the original on 26 October 2012 via Scribd Inc.
  3. Kim EE (2001). "Radioimmunodetection of Cancer". Targeted Molecular Imaging in Oncology. New York, NY: Springer. pp. 88-101 (92). ISBN 9780387950280.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.